Indications for allogeneic HSCT in Europe 1990-2000
| . | No. of patients . | |||
|---|---|---|---|---|
| Total 1990-2000 . | % . | Total 2000 . | % . | |
| Leukemias | 33 509 | 75.9 | 4653 | 72.7 |
| Acute myeloid leukemia | 10 990 | 24.9 | 1627 | 25.4 |
| Acute lymphocytic leukemia | 8 871 | 20.1 | 1135 | 17.7 |
| Chronic myeloid leukemia | 10 559 | 23.9 | 1315 | 20.5 |
| Myelodysplastic syndromes | 2 680 | 6.1 | 454 | 7.1 |
| Chronic lymphocytic leukemia | 409 | 0.9 | 122 | 1.9 |
| Lymphoproliferative disorders | 3 930 | 8.9 | 820 | 12.8 |
| Multiple myeloma | 1 470 | 3.3 | 295 | 4.6 |
| Hodgkin disease | 320 | 0.7 | 68 | 1.1 |
| Non-Hodgkin lymphoma | 2 140 | 4.8 | 457 | 7.1 |
| Solid tumors | 272 | 0.6 | 104 | 1.6 |
| Neuroblastoma | 30 | 0.1 | 1 | 0.0 |
| Glioma | 2 | 0.0 | 1 | 0.0 |
| Soft tissue sarcoma | 13 | 0.0 | 5 | 0.1 |
| Germinal tumors | 10 | 0.0 | 3 | 0.0 |
| Breast cancer | 57 | 0.1 | 16 | 0.2 |
| Ewing sarcoma | 28 | 0.1 | 4 | 0.1 |
| Lung cancer | 1 | 0.0 | 0 | 0.0 |
| Ovarian cancer | 11 | 0.0 | 7 | 0.1 |
| Other solid tumors | 120 | 0.3 | 67 | 1.0 |
| Nonmalignant disorders | 5 695 | 12.9 | 700 | 10.9 |
| Aplastic anemia + Fanconi | 2 483 | 5.6 | 287 | 4.5 |
| Thalassemia | 1 349 | 3.1 | 147 | 2.3 |
| Combined immune deficiencies | 724 | 1.6 | 103 | 1.6 |
| Inborn errors | 1 112 | 2.5 | 153 | 2.4 |
| Autoimmune diseases | 27 | 0.1 | 10 | 0.2 |
| Others | 759 | 1.7 | 127 | 2.0 |
| Total | 44 165 | 6404 | ||
| . | No. of patients . | |||
|---|---|---|---|---|
| Total 1990-2000 . | % . | Total 2000 . | % . | |
| Leukemias | 33 509 | 75.9 | 4653 | 72.7 |
| Acute myeloid leukemia | 10 990 | 24.9 | 1627 | 25.4 |
| Acute lymphocytic leukemia | 8 871 | 20.1 | 1135 | 17.7 |
| Chronic myeloid leukemia | 10 559 | 23.9 | 1315 | 20.5 |
| Myelodysplastic syndromes | 2 680 | 6.1 | 454 | 7.1 |
| Chronic lymphocytic leukemia | 409 | 0.9 | 122 | 1.9 |
| Lymphoproliferative disorders | 3 930 | 8.9 | 820 | 12.8 |
| Multiple myeloma | 1 470 | 3.3 | 295 | 4.6 |
| Hodgkin disease | 320 | 0.7 | 68 | 1.1 |
| Non-Hodgkin lymphoma | 2 140 | 4.8 | 457 | 7.1 |
| Solid tumors | 272 | 0.6 | 104 | 1.6 |
| Neuroblastoma | 30 | 0.1 | 1 | 0.0 |
| Glioma | 2 | 0.0 | 1 | 0.0 |
| Soft tissue sarcoma | 13 | 0.0 | 5 | 0.1 |
| Germinal tumors | 10 | 0.0 | 3 | 0.0 |
| Breast cancer | 57 | 0.1 | 16 | 0.2 |
| Ewing sarcoma | 28 | 0.1 | 4 | 0.1 |
| Lung cancer | 1 | 0.0 | 0 | 0.0 |
| Ovarian cancer | 11 | 0.0 | 7 | 0.1 |
| Other solid tumors | 120 | 0.3 | 67 | 1.0 |
| Nonmalignant disorders | 5 695 | 12.9 | 700 | 10.9 |
| Aplastic anemia + Fanconi | 2 483 | 5.6 | 287 | 4.5 |
| Thalassemia | 1 349 | 3.1 | 147 | 2.3 |
| Combined immune deficiencies | 724 | 1.6 | 103 | 1.6 |
| Inborn errors | 1 112 | 2.5 | 153 | 2.4 |
| Autoimmune diseases | 27 | 0.1 | 10 | 0.2 |
| Others | 759 | 1.7 | 127 | 2.0 |
| Total | 44 165 | 6404 | ||